Erzofri extended-release
NDC 72526-107, paliperidone palmitate, injection, from Shandong Luye Pharmaceutical Co., Ltd..
- Product NDC
- 72526-107
- Status
- Listed
- Labeler
- Shandong Luye Pharmaceutical Co., Ltd.
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216352
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72526-107 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALIPERIDONE PALMITATE117 mg/.75mL
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72526-107-11 | 72526010711 | 1 SYRINGE, GLASS in 1 KIT (72526-107-11) / .75 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/492bf9dd-868e-421a-92db-8cca8973aac1Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=72526-107
Use it
Look up 72526-107 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72526-107 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72526-107. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.